# NEUROPATHIX, INC.

NEUROPATHIX, INC. is a company headquartered in Doylestown, PA, United States.

## Company overview

- **Legal name:** NEUROPATHIX, INC.
- **Former names in filing history:** Kannalife Inc (2018-11-02 to 2020-11-06); TYG Solutions Corp. (2014-09-17 to 2018-10-05); TYG Solutions Inc. (2014-08-21 to 2014-08-21)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Doylestown, PA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001615999

## About

NEUROPATHIX, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001615999, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-04-15, it reported annual revenue of USD 183,477; net income of USD -3,557,786; total assets of USD 224,703 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $183,477 (USD 183,477)
- **Net income:** -$3.6M (USD -3,557,786)
- **Total assets:** $224,703 (USD 224,703)
- **Cash and equivalents:** $15,677 (USD 15,677)
- **Operating cash flow:** -$889,637 (USD -889,637)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$4.5M (USD -4,537,275)
- **Total assets:** $259,661 (USD 259,661)
- **Cash and equivalents:** $21,874 (USD 21,874)
- **Operating cash flow:** -$944,198 (USD -944,198)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $126,027 (USD 126,027)
- **Net income:** -$3.5M (USD -3,450,865)
- **Total assets:** $223,377 (USD 223,377)
- **Cash and equivalents:** $121,455 (USD 121,455)
- **Operating cash flow:** -$1.9M (USD -1,894,085)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $173,889 (USD 173,889)
- **Net income:** $936,815 (USD 936,815)
- **Total assets:** $3.0M (USD 3,022,991)
- **Cash and equivalents:** $307,131 (USD 307,131)
- **Operating cash flow:** -$1.2M (USD -1,210,907)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 10-Q — filed 2022-05-23 — period 2022-03-31 — 10-Q
- Form 10-K — filed 2022-04-15 — period 2021-12-31 — 10-K
- Form 8-K — filed 2022-03-25 — period 2022-03-21 — 8-K
- Form 10-Q — filed 2021-11-12 — period 2021-09-30 — 10-Q
- Form 8-K — filed 2021-09-28 — period 2021-09-28 — 8-K
- Form 10-Q — filed 2021-08-06 — period 2021-06-30 — 10-Q
- Form 10-Q — filed 2021-05-13 — period 2021-03-31 — 10-Q
- Form 10-K — filed 2021-03-30 — period 2020-12-31 — 10-K
- Form 8-K — filed 2021-03-17 — period 2021-03-12 — 8-K
- Form 8-K — filed 2021-02-23 — period 2021-02-17 — 8-K
- Form 8-K — filed 2020-12-21 — period 2020-12-17 — 8-K
- Form 8-K — filed 2020-11-19 — period 2020-11-17 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/neuropathix-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology